ESYS News 13.89 Elecsys Corp (ESYS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Elecsys Corp (ESYS) 13.89 $ESYS

Elecsys Announces New e-Modem Product Family
GlobeNewswire - Mon Apr 07, 9:00AM CDT
Elecsys Corporation (Nasdaq:ESYS), a provider of industrial machine to machine (M2M) communication technology solutions, data acquisition systems, and custom electronic equipment for critical industrial applications, today announced the introduction of the Elecsys e-Modem series of embedded cellular data modems. Elecsys e-Modems are wireless communication devices that are pre-certified to operate on the Verizon Wireless network and are ready to integrate into industrial products to add M2M connectivity. Elecsys, a member of the Verizon Partner Program, worked in cooperation with Verizon to develop the e-Modem series of M2M data modems to address the needs of industry to integrate M2M communications capabilities into remote field applications and rugged equipment.

Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 10, 5:09PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:

Elecsys Corporation Reports Third Quarter Financial Results
GlobeNewswire - Mon Mar 10, 9:00AM CDT
Elecsys Corporation (Nasdaq:ESYS), a provider of innovative machine to machine (M2M) communication technology solutions, data acquisition systems, and custom electronic equipment for critical industrial applications, today announced the financial results for its third fiscal quarter ended January 31, 2014.

Elecsys Has Returned 32.6% Since SmarTrend Recommendation (ESYS)
Comtex SmarTrend(R) - Thu Feb 06, 9:14AM CST
SmarTrend identified an Uptrend for Elecsys (NASDAQ:ESYS) on November 15th, 2013 at $9.44. In approximately 3 months, Elecsys has returned 32.59% as of today's recent price of $12.51.

Elecsys Corporation Announces Appointment of Additional Director
GlobeNewswire - Thu Jan 30, 8:00AM CST
Elecsys Corporation (Nasdaq:ESYS), a provider of innovative machine to machine (M2M) communication technology solutions, data acquisition systems, and custom electronic equipment for critical industrial applications, today announced that George Semb was appointed to the Company's Board of Directors. He was appointed to an additional position that was created as part of the Company's strategy to expand and diversify its board of directors. Mr. Semb's term will run until the next annual meeting of stockholders at which time he will stand for election. It is anticipated that Mr. Semb will be appointed to the Company's audit, nominating, and compensation committees.

Elecsys Up 36.8% Since SmarTrend Uptrend Call (ESYS)
Comtex SmarTrend(R) - Wed Jan 29, 4:53PM CST
SmarTrend identified an Uptrend for Elecsys (NASDAQ:ESYS) on November 15th, 2013 at $9.44. In approximately 3 months, Elecsys has returned 36.83% as of today's recent price of $12.91.

Elecsys Announces the Director Z4 Product
GlobeNewswire - Tue Jan 21, 8:00AM CST
Elecsys Corporation (Nasdaq:ESYS), a provider of industrial machine to machine (M2M) communication technology solutions, data acquisition systems, and custom electronic equipment for critical industrial applications, today announced the addition of the Director Z4 to its Director series of industrial data gateways. The Director Z4 is a secure, flexible edge-of-network device that can remotely connect, monitor, and control a diverse population of mixed field equipment. With the MQTT communication protocol native in the device, the Director Z4 enables easy migration to enterprise data architectures compatible with big data analytics tools while preserving prior investments in existing field equipment. Embedded multi-protocol conversion capabilities make the Director Z4 vendor neutral, enabling seamless integration of virtually every field device.

Shares of ESYS Up 62.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 15, 9:40AM CST
SmarTrend identified an Uptrend for Elecsys (NASDAQ:ESYS) on November 15th, 2013 at $9.44. In approximately 2 months, Elecsys has returned 62.36% as of today's recent price of $15.32.

Elecsys Up 45.1% Since SmarTrend Uptrend Call (ESYS)
Comtex SmarTrend(R) - Wed Jan 08, 9:16AM CST
SmarTrend identified an Uptrend for Elecsys (NASDAQ:ESYS) on November 15th, 2013 at $9.44. In approximately 2 months, Elecsys has returned 45.10% as of today's recent price of $13.69.

Uptrend Call Working As Elecsys Stock Rises 39.9% (ESYS)
Comtex SmarTrend(R) - Tue Dec 31, 5:04PM CST
SmarTrend identified an Uptrend for Elecsys (NASDAQ:ESYS) on November 15th, 2013 at $9.44. In approximately 2 months, Elecsys has returned 39.90% as of today's recent price of $13.20.

Elecsys Shares Up 54.1% Since SmarTrend's Buy Recommendation (ESYS)
Comtex SmarTrend(R) - Tue Dec 24, 11:04AM CST
SmarTrend identified an Uptrend for Elecsys (NASDAQ:ESYS) on November 15th, 2013 at $9.44. In approximately 1 month, Elecsys has returned 54.11% as of today's recent price of $14.54.

Elecsys Corporation Reports Second Quarter Financial Results
GlobeNewswire - Mon Dec 09, 8:00AM CST
Elecsys Corporation (Nasdaq:ESYS), a provider of innovative machine to machine (M2M) communication technology solutions, data acquisition systems, and custom electronic equipment for critical industrial applications, today announced the financial results for its second fiscal quarter ended October 31, 2013.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

IMCD Expands Reach in Latin America with Blumos Acquisition

Updated Category News Views 88

IMCD Expands Reach in Latin America with Blumos Acquisition IMCD N.V. is making significant strides in the life science markets across Latin America through its recent acquisition of the Blumos Group. This move showcases IMCD's commitment to growing its footprint in the region, enhancing its distribution of specialty chemicals and ingredients. About Blumos Group Founded...

Continue Reading
Insights on the Recent Decline of SolarEdge Technologies (SEDG)

Updated Category News Views 129

Understanding the Decline of SolarEdge Technologies SolarEdge Technologies Inc (NASDAQ: SEDG) recently faced a notable decline in its stock price, falling by 5.47% to $17.96. This drop is part of a broader downward trend affecting clean energy stocks, triggered by concerns surrounding the pricing strategies and performance expectations of major players in the solar energy...

Continue Reading
FCP Secures $16.7M for Multifamily Project in Lake Nona

Updated Category News Views 191

FCP Closes $16.7 Million for Royal Palm at Nona Development FCP has announced a significant milestone by closing a $16.7 million preferred equity investment aimed at financing the Royal Palm at Nona project. This 320-unit, Class A multifamily development is set to rise in a rapidly growing submarket. The development is spearheaded by Royal Palm Companies, a reputable firm...

Continue Reading
TeamLinkt Receives Growth Investment to Expand AI Sports Platform

Updated Category News Views 318

TeamLinkt Gains Momentum with Strategic Investment TeamLinkt, a groundbreaking sports management platform, proudly announces a significant minority growth investment from Growth Street Partners. This investment marks an exciting chapter for TeamLinkt as it aims to enhance its technology and expand support services for sports leagues, clubs, and associations....

Continue Reading
Glucose Health Validates Fiber's Importance for Public Well-Being

Updated Category News Views 102

Glucose Health, Inc. Shines a Light on Dietary Fiber's Importance In an important recognition, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA) have identified dietary fiber as a nutrient of public health concern. This announcement holds significant weight for Glucose Health, Inc. (OTC: GLUC), a leader in diabetic...

Continue Reading